Search

Your search keyword '"Monteagudo, Edith"' showing total 253 results

Search Constraints

Start Over You searched for: Author "Monteagudo, Edith" Remove constraint Author: "Monteagudo, Edith"
253 results on '"Monteagudo, Edith"'

Search Results

1. Characterization of a new potent and long-lasting single chain peptide agonist of RXFP1 in cells and in vivo translational models

4. Identification and Optimization of RNA-Splicing Modulators as Huntingtin Protein-Lowering Agents for the Treatment of Huntington’s Disease

6. Conformational dynamics and DNA recognition by human MutSbeta

8. Design and evaluation of [¹⁸F]CHDI-650 as a positron emission tomography ligand to image mutant Huntingtin aggregates

9. Fatty acid acylated peptide therapeutics: discovery of omega-n oxidation of the lipid chain as a novel metabolic pathway in preclinical species

10. Design and Evaluation of [18F]CHDI-650 as a Positron Emission Tomography Ligand to Image Mutant Huntingtin Aggregates

11. Discovery and antiviral profile of new sulfamoylbenzamide derivatives as HBV capsid assembly modulators

12. Identification and in vitro characterization of a new series of potent and highly selective G9a inhibitors as novel anti-fibroadipogenic agents

15. Characterization of a new potent and long-lasting single chain peptide agonist of RXFP1 in cells and in vivo translational models

16. ApoA-I mimetic peptides promote pre-β HDL formation in vivo causing remodeling of HDL and triglyceride accumulation at higher dose

17. Oligomerization, albumin binding and catabolism of therapeutic peptides in the subcutaneous compartment: An investigation on lipidated GLP-1 analogs

21. [11C]CHDI-626, a PET Tracer Candidate for Imaging Mutant Huntingtin Aggregates with Reduced Binding to AD Pathological Proteins

22. Personalized Metabolic Profile by Synergic Use of NMR and HRMS

23. Turnover rate of coenzyme A in mouse brain and liver

24. Conformations of laulimalide in DMSO-d6

25. Identification of Potent and Long-Acting Single-Chain Peptide Mimetics of Human Relaxin-2 for Cardiovascular Diseases

26. Cyclic Phosphopantothenic Acid Prodrugs for Treatment of Pantothenate Kinase-Associated Neurodegeneration

27. Preclinical assessment of capsid assembly modulators (CAMs) of varying potency revealed a novel class of picomolar-acting CAMs inducing neither significant HBcAg cytoplasmic retention nor adverse interactions with HBcAg-specific adaptive immunity

28. Imaging Mutant Huntingtin Aggregates: Development of a Potential PET Ligand

30. Establishment of an in Vitro Human Blood-Brain Barrier Model Derived from Induced Pluripotent Stem Cells and Comparison to a Porcine Cell-Based System

31. 5,6-Dihydroxypyrimidine Scaffold to Target HIV-1 Nucleocapsid Protein

34. Synthesis and Biological Evaluation of RGD–Cryptophycin Conjugates for Targeted Drug Delivery

35. Synthesis of enantiomerically pure 1-alkylimidazoles

38. Application of an in Vitro Blood–Brain Barrier Model in the Selection of Experimental Drug Candidates for the Treatment of Huntington’s Disease

39. Doxorubicin disaccharide analogue: apoptosis-related improvement of efficacy in vivo

41. Improved Selective Class I HDAC and Novel Selective HDAC3 Inhibitors: Beyond Hydroxamic Acids and Benzamides

48. Discovery of a Selective Series of Inhibitors of Plasmodium falciparum HDACs

Catalog

Books, media, physical & digital resources